Diabetes: We Care

A few years ago, Dr. Chen had the opportunity to share in the joys and sorrows of children afflicted with diabetes during an evening outing at a local summer camp.  At the meeting, there were many heartfelt interactions between these children, their families, and Dr. Chen.  What touched Dr. Chen the most, was when a small child, about 2-3 years old, who was diagnosed as type 1 diabetic, put her small hand in Dr. Chen’s hand and showed to Dr. Chen, the child’s painful daily experience to test her blood glucose.  It was while holding the small hand of this child in Dr. Chen’s palm, that Dr. Chen felt that this was a turning point in her life.  It was at that silent moment, that Dr. Chen realized her need to make a difference in the lives of these children, and for other patients with unmet needs. The image of this little girl was forever etched into Dr. Chen’s mind. It has become an everlasting source of strength to encourage ABS to move forward in haste to develop its revolutionary technologies and innovative medical devices for diabetes around the world.
 

  
 

Important Discovery

The ABS team has developed an innovative memristive/memcapacitive device with vertex double-helical polarized biomimetic nanotubule membrane on a gold chip that induced the Fermi arc surface states to occurred at room temperature and the phenomena was observed at the first time.  The new technology enabled us to detect Matrix Matelloproteinase-2 in ag/mL level sensitivity without using any antibody, or reagent in certified NIST’s SRM965A human reference blood serum, Sensors & Transducers, 214(7), 69-84, 2017.

    


Click Here


 

Book

ABS has a book chapter: Nanostructure Biomimetic Sensing and Energy Storage: Organic Memristor/Memcapacitors in Dekker Encyclopedia of Nanoscience and Nanotechnology, Third Edition; Lyshevski, S. Ed.; Taylor and Francis: New York, 2017. Published online. January 18, 2017. DOI: 10.1081/E-ENN3-120054061.

ABS’s work in Biomimetic Sensing and Energy Storage, as a chapter was included in the collection of Dekker Encyclopedia of  Nanoscience and Nanotechnology in the first volume, Third Edition, edited by Lyshevski SE, March 20, 2014 at www.crcpress.com.

Patents Award

A US Patent No. 9,443,665 was granted in the title of Nanobiomimetic supercapacitors with high rate high energy storage  and was issued on September 13, 2016 by the US Patent and Trademark Office. 

Another US Patent No. 9,534,999 was granted in the tile of A nanostructured biomimetic device for detecting a cancer cell or cancer cells and was issued by the US Patent and Trademark Office on January 3, 2017.

The US Patent Office issued a Notice of Allowance to the US patent application No.14/919, 606 on June 7, 2017.  The patent No. 9,793,503 was issued by the US Patent and Trademark Office on October 17, 2017.  

A patent # 8,632,925 was issued by the US Patent Office on January 21, 2014. A patent # 8,641,876 was issued on February 4, 2014.  

National Innovation Showcase

ABS’s nanobiomimetic reagent-free technology platform will be honored and listed in the National Innovation Showcase and in the International Innovation Showcase at the Tech Connect World Conference on May 15-17, 2017 at Washington, DC. 

ABS won TechConnect National Innovation Award for its Nanobiomimetic Reagent-free Sensing and Energy Storage platform technology, May 15, 2017 at Gaylord Convention Center, Techconnect World Conference www.techconnectworld.com.  

 

 

Press Releases

  1. Wednesday, January 29, 2014

    A New Patent was issued

    A new patent # 8,632,925 was issued in the title of Apparatus and Methods for Making High Performance Fuel Cell by the US Patent Office on January 21, 2014. The inventor is Dr. E. Chen.

    Read Press Release ยป
  2. Tuesday, November 29, 2011

    The US Patent Office issued an allowable letter for Nanopore Structured Electrochemical Biosensors

    The U.S. Patent and Trademark Office (USPTO) issued an allowable letter on July 21, 2011 for a patent application titled Nanopore structured Electrochemical Biosensors.

See All Releases »

PR Contacts

  1. Ellen Chen

    CEO

    240-706-5687

  2. Dr. Chen

    CEO

    240-706-5687